Precision Cancer Medicine
Search All News
Spotlighting new research from the Momen-Heravi lab on immunotherapy response in head and neck cancer and other solid tumor types.
A new study by Elham Azizi and Ben Izar shows a new technique to study cancer tissues archived in biobanks, increasing the variety of samples for analysis and the discovery of biomarkers.
Exciting new clinical investigations, including results of the ALPINE study, show promising, more effective treatment for patients with CLL.
- June 5, 2021
Results of a new phase 2 clinical trial demonstrate the potential of targeted therapy in combination with chemotherapy to treat patients with uterine leiomyosarcoma.
- June 3, 2021
Five teams of researchers are awarded pilot grants to conduct innovative basic science, translational, and clinical research across multiple diseases.
- May 11, 2021
In a new study by Adam Bass, MD, scientists have found that many esophageal cancers turn on ancient viral DNA embedded in our genome, a finding that could lead to improvements in immunotherapy.
Source:CUIMC NewsroomOctober 29, 2020
Adam Bass, MD, joins the HICCC as the founding director of the Center for Precision Cancer Medicine and director of gastrointestinal oncology.